Agencies worldwide are cracking down on counterfeit pharmaceuticals, and much of the focus has been on China, where an official was recently executed for approving fake medicines. While most of these drugs reach consumers through online or illegal suppliers, there’s a growing threat to outlets considered more safe, like the neighborhood pharmacy, said Temple University pharmacoeconomist, Albert Wertheimer, Ph.D., who will talk about combating counterfeit pharmaceuticals coming out of China at a U.S. Patent and Trademark Office (USPTO) seminar on July 23 and 24 in Philadelphia
